Weiss Multi-Strategy Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,841	Closed	-$3.89M	–	548
2023 Q3	$3.89M	Buy	10,841 +742	+7%	+$286K	0.09%	278
2023 Q2	$3.83M	Buy	+10,099	New	+$4.11M	0.08%	342
2023 Q1	–	Sell	-8,585	Closed	-$3.61M	–	628
2022 Q4	$3.61M	Buy	8,585 +261	+3%	+$105K	0.1%	282
2022 Q3	$3.47M	Buy	8,324 +2,715	+48%	+$1.35M	0.09%	306
2022 Q2	$2.78M	Buy	+5,609	New	+$2.92M	0.08%	330
2014 Q2	–	Sell	-1,650	Closed	-$211K	–	731
2014 Q1	$211K	Buy	+1,650	New	+$212K	﹤0.01%	905

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Weiss Multi-Strategy Advisers's BIO Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 10,841 shares — an estimated $3.89M sold.

Weiss Multi-Strategy Advisers first reported a position in BIO in Q1 2014 and held it in 6 quarters. The position peaked at $3.89M in Q3 2023. 483 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

Weiss Multi-Strategy Advisers reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 10,841 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $3.89M.
Weiss Multi-Strategy Advisers first reported a position in Bio-Rad Laboratories Class A in Q1 2014 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's Bio-Rad Laboratories Class A position peaked at $3.89M in Q3 2023.
483 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.